Vimarsana
Biggest News Aggregation in the World

Prognostic Value News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prognostic Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prognostic Value Today - Breaking & Trending Today

Advanced CT test simulates blood flow to evaluate risk in patients with angina - Vimarsana News

Advanced CT test simulates blood flow to evaluate risk in patients with angina

Denmark: A normal coronary CT angiography (CTA)-derived fractional flow reserve (FFR) test result identified patients with a low 3-year risk of all-cause death or nonfatal spontaneous MI, both in the...

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague - Vimarsana News

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague

Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the investigator-initiated phase II study using uPAR-PET (uTRACE®) in primary brain cancer have been presented in an oral presentation at the World Molecular Imaging Congress (WMIC) 2023 in ...

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague - Vimarsana News

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague

/PRNewswire/ -- Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the...

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WM - Vimarsana News

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WM

COPENHAGEN, Denmark, Sept. 14, 2023 /PRNewswire/ -- Curasight A/S ("Curasight" or the "Company" - TICKER:...

Curasight A/S Announces Positive Results from the Phase II Study of uTRACE in Brain Cancer Presented at the World Molecular Imaging Congress 2023 in Prague - Vimarsana News

Curasight A/S Announces Positive Results from the Phase II Study of uTRACE in Brain Cancer Presented at the World Molecular Imaging Congress 2023 in Prague

Curasight A/S announced that the previously announced results from the investigator-initiated phase II study using uPAR-PET in primary brain cancer have been presented in an oral presentation at the...